Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Mental health

New Alzheimer's blood test could detect disease '10 years' before symptoms appear

Scientists have discovered that a type of protein could be a blood-marker for early signs of the disease.

Daily Record

Blood markers ‘may reveal rare form of Alzheimer’s 10 years before symptoms’

Scientists hope their work could lead to earlier detection.

The Independent UK

Concern as proportion of children in England on antipsychotics doubles

Researchers find overall percentage increase from 0.06% in 2000 to 0.11% in 2019 although safety in children not fully established

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

How to reduce your risk of Parkinson's disease

If you think Parkinson's disease only affects old people, think again - but there are some lifestyle changes you can make to dramatically reduce your changes of getting the neurological condition.

Newsroom.co.nz

Five symptoms of dementia and early warning signs

One in four sufferers commonly go two years undiagnosed, one study claims

The Independent UK

Mayo Clinic expert provides perspective on FDA approval of another experimental Alzheimer's drug

The Food and Drug Administration granted accelerated approval of a disease-modifying treatment that could potentially give some patients with Alzheimer's disease something they haven't had before: a medication that may slow the decline of memory and thinking.

Tribune News Service

Row over 'template letter' to inform patients of alleged mental health crisis in Tasmania's north

The wording of a letter informing patients their mental health service is in crisis is "a template, in case it's needed in the future", Tasmania's health department says — but a health union says it shows mental health care is "in such a state it might be embarrassing to admit".

ABC News

Read news from The Economist, FT, and more,
with one subscription

Finally, a new drug slows Alzheimer’s, but is it worth the price for modest benefit?

Leqembi can slow early progression by months but has safety concerns. Most patients will likely have to wait months to get the IV drug, which will cost about $26,500 a year. Insurers need to decide whether and how much to cover it. Medicare isn’t expected to pay for it until…

Chicago Sun-Times

Five symptoms of dementia and early warning signs

One in four sufferers commonly go two years undiagnosed, one study claims

The Independent UK

ADHD symptoms and warning signs including poor sleep

Sometimes ADHD is not recognised when someone was a child, and they are diagnosed later as an adult

Liverpool Echo

Fixing the youth mental health crisis

Students are more stressed than ever — and the best (and most obvious) solution is hiring enough school counselors

Salon

Practicing one whimsical activity may stave off brain aging — study

Opinion: Lifestyle interventions like social ballroom dancing are a promising, noninvasive, and cost-effective path toward staving off dementia as we – eventually – leave the Covid-19 pandemic behind.

Inverse

Scientists reveal how to spot signs of dementia nine years before diagnosis

Early intervention could reduce your risk of developing dementia-related disease

The Independent UK

US Approves New Drug to Treat Alzheimer's Disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease. The FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticized…

Asharq Al-Awsat

Get all your
news in one place.

100's of premium titles.
One news app.

Liverpool Echo

Parkinson's symptom that starts years before hand tremors

Parkinson's is a degenerative, neurological condition with no cure

The Philadelphia Inquirer

The FDA approved the first Alzheimer’s drug that may really work. A Penn physician explains why you probably can’t get it, yet

The FDA on Friday authorized the use of the Alzheimer’s drug lecanemab, the first drug clearly shown to slow the progress of the debilitating brain disease.

The Independent UK

New hope for Alzheimer’s sufferers as FDA gives fast-track approval to experimental drug

The study also showed that Leqembi carries a risk of brain swelling and bleeding

The Independent UK

Alzheimer’s drug that slows disease progression approved by FDA

U.S. health officials have approved a new Alzheimer’s drug that modestly slows the brain-robbing disease

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Alzheimer's drug that modestly slows disease OK'd by FDA

U.S. health officials have approved a new Alzheimer’s drug that modestly slows the brain-robbing disease

Daily Mirror

Brits putting their health at risk by not taking a simple hearing test, charity says

The Royal National Institute for Deaf People (RNID) says only 6% of people in the UK who have not been diagnosed with hearing loss had a hearing test last year, compared with 46% who took an eye test

Chicago Tribune

Commentary: We need to take bold steps to help our struggling youths in 2023

Starting the new year with legislation that prohibits anyone younger than 18 from having a social media account would benefit our youths. In Texas, that could become a reality. A state representative there has proposed legislation that would ban minors from having social media profiles. While it certainly will be…

Daily Mirror

Participant taking part in experimental trial for Alzheimer's drug dies suddenly

A 65-year-old has died after taking part in an experimental clinical trial for Alzheimer’s disease, with a new study saying their passing could have been related to the drug

The Independent UK

Travelling to see family and friends ‘good for health’

Experts found that people who left their local community were more likely to report good health compared to those who stayed closer to home.

The Independent UK

Five symptoms of dementia and early warning signs

One in four sufferers commonly go two years undiagnosed, one study claims

Salon

America's loneliness fuels fascism

Both young Americans and seniors feel increasingly isolated — and this problem is central to our political crisis

1 … 135 136 137 138

People

Donald Trump

175,796 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

336 stories

Alzheimer Society

225 stories

University of Cambridge

University of Manchester

US Food and Drug Administration

62 stories

Karolinska Institutet

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.